Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention

Trial Profile

Effect of Ranolazine on Activity Level in Patients With Angina After FFR Based Deferred Intervention

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 09 Feb 2017

At a glance

  • Drugs Ranolazine (Primary)
  • Indications Angina pectoris
  • Focus Therapeutic Use
  • Acronyms REPTAR
  • Most Recent Events

    • 09 Feb 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top